Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-21 Sale |
2022-12-22 1:24 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
2,031 | $43.96 | $89,283 | 16,197 (Direct) |
View |
| 2022-10-14 Sale |
2022-10-17 6:49 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Dier Mardi CFO & Executive Vice President |
1,629 | $40.16 | $65,421 | 66,695 (Direct) |
View |
| 2022-10-12 Sale |
2022-10-14 12:58 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Dier Mardi CFO & Executive Vice President |
3,484 | $38.22 | $133,158 | 68,324 (Direct) |
View |
| 2022-06-19 Sale |
2022-06-22 7:27 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
295 | $54.78 | $16,160 | 36,160 (Direct) |
View |
| 2022-04-16 Sale |
2022-04-19 12:56 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
132 | $84.55 | $11,161 | 16,914 (Direct) |
View |
| 2022-03-11 Sale |
2022-03-15 4:33 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
10,281 | $67.01 | $688,930 | 227,559 (Direct) |
View |
| 2022-03-07 Sale |
2022-03-08 12:25 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
5,140 | $62.95 | $323,563 | 34,438 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 6:12 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Dier Mardi CFO & Executive Vice President |
954 | $65.71 | $62,686 | 76,708 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 6:11 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
2,713 | $66.62 | $180,740 | 61,217 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 6:10 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks |
4,498 | $66.62 | $299,657 | 84,166 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 6:09 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
843 | $66.62 | $56,161 | 24,446 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 6:09 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks |
3,234 | $66.62 | $215,449 | 75,940 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 6:08 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
2,886 | $66.62 | $192,265 | 64,478 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 6:07 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
2,374 | $66.62 | $158,156 | 252,740 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 6:07 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
2,821 | $66.62 | $187,935 | 72,838 (Direct) |
View |
| 2022-01-30 Sale |
2022-02-01 1:39 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
1,657 | $66.3 | $109,859 | 36,759 (Direct) |
View |
| 2021-10-14 Sale |
2021-10-18 7:02 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
359 | $81.14 | $29,129 | 38,416 (Direct) |
View |
| 2021-10-14 Sale |
2021-10-18 6:58 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
303 | $81.14 | $24,585 | 25,030 (Direct) |
View |
| 2021-10-14 Sale |
2021-10-18 6:55 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl EVP & Chief Tech Ops Officer |
358 | $81.14 | $29,048 | 40,148 (Direct) |
View |
| 2021-10-14 Sale |
2021-10-18 6:53 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
140 | $81.14 | $11,360 | 14,072 (Direct) |
View |
| 2021-10-14 Sale |
2021-10-18 6:48 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
286 | $81.14 | $23,206 | 216,266 (Direct) |
View |
| 2021-10-14 Sale |
2021-10-18 6:46 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
310 | $81.14 | $25,153 | 28,358 (Direct) |
View |
| 2021-10-14 Sale |
2021-10-18 6:41 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks |
358 | $81.14 | $29,048 | 49,764 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-09-16 Option Award |
2022-09-19 9:39 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Dier Mardi CFO & Executive Vice President |
20,000 | $0 | 71,808 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-08 6:36 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
1,000 | $0 | 18,094 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-29 3:48 pm |
N/A 2032-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | Sanders Corazon (Corsee) D. Director |
9,545 | $0 | 13,440 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 1:54 pm |
N/A 2032-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | WELCH DANIEL G Director |
9,545 | $0 | 23,990 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 1:53 pm |
N/A 2032-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | Ekman Lars Director |
9,545 | $0 | 23,990 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 1:52 pm |
N/A 2032-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
9,545 | $0 | 32,740 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 1:51 pm |
N/A 2032-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | NARACHI MICHAEL Director |
9,545 | $0 | 23,990 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 1:50 pm |
N/A 2032-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | Ray Amrit Director |
9,545 | $0 | 14,665 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 1:48 pm |
N/A 2032-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | SULIMAN SHEHNAAZ Director |
9,545 | $0 | 17,240 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 1:48 pm |
N/A 2032-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director |
9,545 | $0 | 22,115 (Direct) |
View |
| 2022-04-19 Option Award |
2022-04-22 12:31 pm |
N/A 2032-04-19 |
Ultragenyx Pharmaceutical Inc. | RARE | Ray Amrit Director |
14,645 | $0 | 14,645 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 12:25 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
7,500 | $40.37 | 23,195 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 12:25 pm |
N/A 2024-07-10 |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
7,500 | $0 | 23,195 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 6:12 pm |
N/A 2032-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Dier Mardi CFO & Executive Vice President |
38,900 | $0 | 76,708 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 6:11 pm |
N/A 2032-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
38,900 | $0 | 61,217 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 6:10 pm |
N/A 2032-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks |
38,900 | $0 | 84,166 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 6:09 pm |
N/A 2032-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
11,110 | $0 | 24,446 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 6:09 pm |
N/A 2032-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks |
38,900 | $0 | 75,940 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 6:08 pm |
N/A 2032-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
38,900 | $0 | 64,478 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 6:07 pm |
N/A 2032-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
38,900 | $0 | 252,740 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 6:07 pm |
N/A 2032-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
38,900 | $0 | 72,838 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 6:06 pm |
N/A 2032-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
144,401 | $0 | 2,936,327 (Direct) |
View |
| 2022-03-01 Tax Withholding |
2022-03-03 6:06 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
12,162 | $67.37 | 2,936,327 (Direct) |
View |
| 2021-12-10 Ownership |
2022-02-01 1:42 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
52 | $0 | 216,214 (Direct) |
View |
Ownership |
2022-02-01 1:41 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
0 | $0 | 2,804,088 (Direct) |
View |
| 2021-12-10 Ownership |
2022-02-01 1:41 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
50,000 | $0 | 2,804,088 (Indirect) |
View |
| 2021-09-13 Gift |
2021-10-18 6:53 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
819 | $0 | 14,072 (Direct) |
View |
| 2021-10-14 Tax Withholding |
2021-10-18 6:44 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
853 | $81 | 2,854,088 (Direct) |
View |